BiotechTube

Ryanodex (dantrolene sodium) for injectable suspension

Phase 2Terminated
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Toxicity Psychotropic Agents Psychostimulants

Conditions

Drug Toxicity Psychotropic Agents Psychostimulants

Trial Timeline

Aug 12, 2017 → Dec 31, 2018

NCT ID
NCT03189433

About Ryanodex (dantrolene sodium) for injectable suspension

Ryanodex (dantrolene sodium) for injectable suspension is a phase 2 stage product being developed by Eagle Pharmaceuticals for Drug Toxicity Psychotropic Agents Psychostimulants. The current trial status is terminated. This product is registered under clinical trial identifier NCT03189433. Target conditions include Drug Toxicity Psychotropic Agents Psychostimulants.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03189433Phase 2Terminated

Competing Products

20 competing products in Drug Toxicity Psychotropic Agents Psychostimulants

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
40
GP404141 + NplateGEROPHARMPhase 3
69
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
33
EC905 + verapamilAstellas PharmaPhase 1
33
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
33
enzalutamide + rifampinAstellas PharmaPhase 1
33
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
33
CefiderocolShionogiApproved
85
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
33
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
33
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
77
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
33
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77

Other Products from Eagle Pharmaceuticals

Arm 1 Cataract Surgery performed with remimazolam as sedative + Arm 2 Cataract Surgery performed with standard of care sedativeApproved
77
Placebo + Mesalamine + MesalaminePhase 3
69
Ryanodex and Standard of CarePhase 3
69
CAL02 + PlaceboPhase 2
44
Dantrolene sodium for injectable suspensionPhase 2
44